| Company Name: |
BOC Sciences
|
| Tel: |
|
| Email: |
info@bocsci.com |
| Products Intro: |
Product Name:Daglutril
CAS:182821-27-8
Purity:99% Remarks:Daglutril is a dual endothelin converting enzyme (ECE)/neutral endopeptidase (NEP) inhibitor used for the treatment of hypertension and heart failure andpulmonary. It reduces proteinuria and urinary a
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
4008200310 |
| Email: |
marketing@tsbiochem.com |
| Products Intro: |
Product Name:Daglutril
CAS:182821-27-8
Package:100mg/RMB 17500;25mg/RMB 10600;50mg/RMB 13800
|
SLV 306 manufacturers
- Daglutril
-
- $2500.00 / 100mg
-
2025-08-21
- CAS:182821-27-8
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | SLV 306 Basic information |
| Product Name: | SLV 306 | | Synonyms: | SLV 306;Daglutril;2-((S)-3-(1-((R)-2-(ethoxycarbonyl)-4-phenylbutyl)cyclopentanecarboxamido)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetic acid;Daglutril - SLV 306;1H-1-Benzazepine-1-acetic acid, 3-[[[1-[(2R)-2-(ethoxycarbonyl)-4-phenylbutyl]cyclopentyl]carbonyl]amino]-2,3,4,5-tetrahydro-2-oxo-, (3S)- | | CAS: | 182821-27-8 | | MF: | C31H38N2O6 | | MW: | 534.64 | | EINECS: | | | Product Categories: | | | Mol File: | 182821-27-8.mol |  |
| | SLV 306 Chemical Properties |
| Boiling point | 802.3±65.0 °C(Predicted) | | density | 1.25±0.1 g/cm3(Predicted) | | pka | 3.73±0.10(Predicted) |
| | SLV 306 Usage And Synthesis |
| Uses | Daglutril is a compound with the potential to regulate cytokine-induced endothelin-1 production in astrocytes. In studies, it has an inhibitory effect on the production of endothelin-1 induced by some cytokines and can be used as a tool to screen compounds that inhibit endothelin-1 production in astrocytes. | | References | [1] Modulation of Cytokine-Induced Astrocytic Endothelin-1 Production as a Possible New Approach to the Treatment of Multiple Sclerosis DOI:10.3389/fphar.2019.01491 |
| | SLV 306 Preparation Products And Raw materials |
|